Bathi operasional sadurunge amortisasi: acrivon.com (ACRV)

Logo perusahaan publik Acrivon Therapeutics, Inc. (ACRV)

Why does Acrivon Therapeutics (ACRV) command such deep confidence from scientists and investors? Acrivon Therapeutics is developing precision oncology for the B2B sector, utilizing protein profiles to predict patient response. This ensures success where conventional methods fail. The EBITDA trend confirms financial stability, and the 0.00 mark records this specific operating profit figure before depreciation and amortization.

Bathi sadurunge mbayar bunga, pajak, lan amortisasi Acrivon Therapeutics, Inc. (ACRV): kanggo periode 23.11.2025 - 12.11.2026

Ringkesan rincian data analitis Acrivon Therapeutics, Inc. (ACRV)

- rega pasar lan target rega analis:
Rega saham Acrivon Pharma|ACRV - Bagan rega target
- indikator kapitalisasi bursa perusahaan:
Kapitalisasi pasar Acrivon Therapeutics|ACRV - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Aset Bersih saben Saham Acrivon Therapeutics|ACRV - Nilai Buku Perusahaan|Koefisien Nilai Pasar marang Nilai Buku acrivon.com|ACRV - Gunggung Aset Perusahaan
- rincian struktur utang lan likuiditas bisnis:
Total Utang marang Modal Acrivon Therapeutics|ACRV - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal Acrivon Therapeutics Inc|ACRV - Gunggung utang perusahaan|Rasio utang marang aset resik Acrivon Therapeutics|ACRV - Utang jangka dawa perusahaan|Utang jangka cendhak Acrivon Therapeutics|Rasio likuiditas darurat acrivon.com
- rincian bathi lan kelipatan pasar:
ACRV - Bathi resik|Bathi mangsa ngarep Acrivon Therapeutics|ACRV - Rasio rega marang bathi|Rasio prakiraan rega marang bathi acrivon.com|ACRV - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Acrivon Therapeutics|ACRV - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Acrivon Therapeutics|ACRV - Bathi resik saben saham (EPS TTM)|Wutah bathi resik saben saham sajroning taun lumaku acrivon.com|ACRV - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham ing taun ngarep Acrivon Therapeutics
Pambiji fundamental perusahaan:Acrivon Pharma
Produk asli Acrivon

For Acrivon Therapeutics (ACRV), which invests accumulated cash into costly oncology research, the EBITDA_Co trend visualizes the dynamics of operating cash flow excluding depreciation and debt service. This indicator measures the business's actual ability to generate cash, allowing investors to assess the risk of capital freeze and the company's liquidity resilience amid macroeconomic pressure or recession.

Pesaing Acrivon Therapeutics (ACRV)

Bathi operasional EBITDA Novocure NVCR|DRTS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|FBIO (fortressbiotech.com) - Bathi operasional sadurunge amortisasi|ALLR: Bathi operasional EBITDA